🌟 Pharmidex is delighted to welcome Dr. Vasudha Tandon, PhD 🌟
September 23, 2025
We are proud to announce that Vasudha has recently joined us as Principal Scientist in In Vivo Pharmacology. With her expertise and passion for advancing drug discovery, Vasudha will be a key contributor to our mission of delivering high-quality preclinical research and innovative solutions to our partners.
Please join us in giving her a very warm welcome to the Pharmidex family! 💙
#Pharmidex #DrugDiscovery #InVivoPharmacology #TeamPharmidex
We’re excited to welcome Grace Horne as our new Bioanalytical Scientist! 🎉 Grace brings great enthusiasm and passion for science, and we’re confident she’ll make a fantastic contribution to our team. Welcome aboard, Grace, we’re thrilled to have you with us! 💜
We’re pleased to share that Janette Dalay Robertson , Business Development Manager at Pharmidex , will attend the DDW Turning Science into Business Symposium 2025 on Tuesday, 4th November, at the The Francis Crick Institute , London. Janette looks forward to connecting with industry leaders and exploring new collaboration opportunities.
We’re delighted to announce that Pharmidex will present our poster "Driving breakthroughs in Parkinson’s & neurodegeneration research” at the upcoming RSC BMCS meeting. With over 23 years of CNS expertise, we support biopharma partners in developing new therapies for Parkinson’s disease and tauopathies, through: 🔹 Parkinson’s & neurodegeneration models 🔹 Transgenic CNS lines (incl. 5xFAD) 🔹 Biomarker & BBB penetration studies Join us in Cambridge to explore how our GLP-accredited CNS platforms accelerate discovery and development.
